Filing Details

Accession Number:
0001686266-17-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-27 14:52:53
Reporting Period:
2017-03-22
Filing Date:
2017-03-27
Accepted Time:
2017-03-27 14:52:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138776 Aevi Genomic Medicine Inc. GNMX Biological Products, (No Disgnostic Substances) (2836) 980217544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181073 R Philip Harper 1850 Rose Cottage Lane
Malvern PA 19355
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-22 1,000,000 $1.79 4,786,682 No 4 P Direct
Common Stock Acquisiton 2017-03-23 4,705 $1.60 4,791,387 No 4 P Direct
Common Stock Acquisiton 2017-03-24 53,826 $1.60 4,845,213 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 220,000 Indirect By wife
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.80, inclusive. The reporting person undertakes to provide to the issuer, its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.